Hepatitis
exp date isn't null, but text field is
Hepatitis is an inflammation or injury of the liver with multiple causes. It may present as an acute illness with jaundice and altered liver function tests.
Causes
Viral hepatitis |
Non-viral hepatitis |
- Hepatitis A virus (HAV) - Hepatitis B virus (HBV) - Hepatitis C virus (HCV) - Hepatitis D virus (HDV) - Hepatitis E virus (HEV) |
- Bacteria - Autoimmune - Parasites - Fungi - Alcohol - Medicines - Toxins - Haemorrhagic fevers (Ebola and Marburg) |
Hepatitis virus |
Transmission route |
Incubation period (days) |
Serological markers |
Complications |
HAV |
- Oro-faecal |
15–50 |
- Anti-HAV IgM |
- Recovery in about 3 months - No chronic phase |
HBV |
- Sexual - Blood-contaminated instruments - Contaminated blood products - Mother to child |
30-180 |
- HBsAg - Anti-HBc - HBeAg |
- Fulminant hepatitis - Cirrhosis - Hepatocellular Carcinoma |
HCV |
- Blood-contaminated instruments - Rarely - Sexual - Mother to child |
14–180 |
- Anti-HCV IgM - HCV RNA |
- Cirrhosis - Hepatocellular Carcinoma |
HDV |
- Blood-contaminated instruments - Rarely - Sexual - Mother to child |
45–160
|
- HDV-RNA - Anti-HDV IgM |
- Fulminant hepatitis - High risk of severe chronic liver disease |
HEV |
- Oro-faecal |
15–64 |
Anti-HEV IgM |
- Fulminant hepatitis - High mortality rate in pregnant women |
Signs and symptoms
Acute hepatitis
- May be asymptomatic
- Prodromal phase presents with non-specific and flu-like symptoms
- Fever
- Fatigue
- Malaise
- Abdominal discomfort (right upper quadrant)
- Nausea
- Diarrhoea
- Anorexia
Followed by
- Jaundice
- Dark urine
- Clay coloured stool
Chronic hepatitis
- May be asymptomatic
- Weakness and malaise
- Low grade fever
- Nausea
- Loss of appetite
- Vomiting
- Pain or tenderness over the right upper abdomen
- Jaundice
- Dark urine, severe pruritus
- Enlarged liver
Investigations
- Complete blood count
- Liver function tests
- Serology for Hepatitis A,B,C,D, E
- Abdominal ultrasound scan
- Slide or RDT for malaria parasites
Management
Virus type |
Treatment objectives |
Treatment |
Complications |
Prevention |
HAV |
- Reduce symptoms |
- Supportive |
- Recovery in about 3 months - No chronic phase |
- Safe drinking water - Food hygiene - Immunization |
HBV |
- Reduce symptoms - Prevent complications - Inhibit viral replication |
- Acute: supportive - Chronic: interferon α- or tenofovir |
- Fulminant hepatitis - Cirrhosis - Hepatocellular Carcinoma |
- Safe sex - Screen blood products - Use sterile instruments - HBV vaccination - PEP |
HCV |
- Decrease replication or eradicate HCV - Prevent disease progression to cirrhosis and hepatocellular carcinoma - Reduce symptoms - Treat extrahepatic complications |
- Acute: interferon-α or peginterferon-α Chronic: interferonα plus ribavirin or DAAs (cure possible) - Liver transplantation |
- Cirrhosis - Hepatocellular Carcinoma |
- Safe sex - Screen blood products - Use sterile instruments - No vaccination available - No PEP |
HDV |
- Reduce symptoms |
- Peginterferon-α PLUS Lamivudine |
- Fulminant hepatitis - High risk of severe chronic liver disease |
- Safe sex - Screen blood products - Use sterile instruments - HBV vaccination - PEP |
HEV |
- Reduce symptoms |
- Acute: supportive |
- Fulminant hepatitis - High mortality rate in pregnant women |
- Safe drinking water - Food hygiene
|
Non-pharmacological management
- Encourage rest and hydration
- Encourage high intake of carbohydrates and vegetable proteins.
- Discourage intake of animal proteins e.g. meat
- Avoid unnecessary medicines, especially sedatives and hepatotoxic drugs
- No alcohol consumption
- Avoid ferrous a
- Limit vitamin supplements that contain fat-soluble vitamins and vitamin C
- Ensure effective infection control measures
Pharmacological management
Hepatitis B Virus (HBV)
Tenofovir oral
300mg once daily for life
OR
Entecavir oral
0.5mg–1mg once daily for life
OR
Lamivudine oral
100mg once daily for life
Hepatitis C Virus (HCV)
Ledipasvir oral
90mg in divided doses orally for 12–24 weeks
PLUS
Sofosbuvir oral
400mg in divided doses for 12–24 weeks
PLUS
Ribavirin oral
600mg–1000mg in divided doses for 12–24 weeks
Referral
- Refer negative results for Hepatitis A & B for vaccination
- Refer all positive cases for specialist care